Clinical Research Open Access
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 1, 2004; 10(7): 1052-1055
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1052
Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese women
Hiroshi Sakugawa, Tomofumi Nakayoshi, Kasen Kobashigawa, Hiroki Nakasone, Yuko Kawakami, Tsuyoshi Yamashiro, Tatsuji Maeshiro, Ko Tomimori, Satoru Miyagi, Fukunori Kinjo, Atsushi Saito, First Department of Internal Medicine, Faculty of Medicine, School of Medicine, University of the Ryukyus, Okinawa, Japan
Author contributions: All authors contributed equally to the work.
Correspondence to: Hiroshi Sakugawa, M.D., First Department of Internal Medicine, University Hospital, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Okinawa, 903-0125, Japan. b987607@med.u-ryukyu.ac.jp
Telephone: +98-895-1144 Fax: +98-895-1414
Received: September 23, 2003
Revised: October 23, 2003
Accepted: December 19, 2003
Published online: April 1, 2004

Abstract

AIM: This study aimed to determine whether metabolic syndrome is directly or indirectly, through fatty liver, associated with elevated gamma-glutamyl transpeptidase (GGT) levels in Japanese women.

METHODS: From 4366 women who received their annual health check-up, 4211 women were selected for analysis. All 4211 women were negative for both hepatitis B surface antigen and antibody to hepatitis C virus. Clinical and biochemical variables were examined by using univariate and multivariate analysis.

RESULTS: A raised GGT level ( > 68 IU/L) was seen in 258 (6.1%) of the 4211 women. In univariate analysis, all variables examined (age, body mass index, blood pressure, hemoglobin concentration, fasting blood glucose, glycosylated hemoglobin A1c, cholesterol, triglyceride, and uric acid) were associated with the elevated GGT level, whereas in multivariate analysis, four variables (age ≧ 50 yr, hemoglobin ≧ 14 g/dL, triglyceride ≧ 150 mg/dL, and presence of diabetes) were significantly and independently associated with raised GGT level. Clinical variables predicting the presence of ultrasonographic evidence of fatty liver were also examined by multivariate analysis; four variables were associated with the presence of fatty liver: BMI ≧ 25 kg/m2, hemoglobin ≧ 14 g/dL, triglyceride ≧ 150 mg/dL, and uric acid ≧ 7 mg/dL. There was no significant association between the raised GGT level and the presence of fatty liver. Hypertriglyceridemia was significantly and independently associated with both the raised GGT level and the presence of fatty liver.

CONCLUSION: Metabolic syndrome seemed to be directly, not indirectly through fatty liver, associated with the raised GGT level in Japanese women.




INTRODUCTION

The prevalence of overweight persons is increasing in developed and developing countries[1-3]. Obesity is strongly associated with insulin resistance[4-6], which is known to be associated with an elevated gamma-glutamyl transpeptidase (GGT) level[7,8]. However, the mechanism of the relationship between insulin resistance and GGT elevation has not yet been clarified. Metabolic syndrome is associated with insulin resistant status[4-6], and is increasing recently in Japan together with an increase in the prevalence of obesity[2]. It is well known that insulin resistance is associated with fatty liver[9,10]. Furthermore, fatty liver is associated with elevated GGT levels[8]. Hence, the following question emerged: is insulin resistant status directly or indirectly, through fatty liver, associated with GGT elevation? Few population-based studies have been performed on the association between raised GGT level and metabolic syndrome[7,8]. Moreover, these studies usually dealt with men[8,11]. It is well known that GGT elevation is frequently induced by habitual alcohol intake and drinkers are more frequently included among men than women. Most raised GGT levels seen in ordinary women are not caused by alcohol, because women with a history of regular alcohol intake in Japan are rare[12]. However, nonalcoholic steatohepatitis (NASH), a severe form of nonalcoholic fatty liver disease, is known to be associated with female gender, metabolic syndrome, and raised GGT level[10]. Hence, a general population study on the association of raised GGT level with risk factors of metabolic syndrome among women is urgently needed.

The aim of this study was to determine whether metabolic syndrome is directly or indirectly, through fatty liver, associated with GTP elevation in Japanese women.

MATERIALS AND METHODS
Subjects

From January 2000 to December 2000, 4366 women received their annual health check-up at the Okinawa General Health Service Association. They were all Japanese aged between 21 and 88 years: 87% were 40 years of age or older.

Methods

For all women, the body mass index (BMI; kg/m2) was calculated. Obesity was defined as BMI ≧ 25 kg/m2 as recommended by the Japan Society for Obesity[13].

Laboratory tests included peripheral blood cell counts, liver function tests (aspartate aminotransferase (AST), alanine aminotransferase (ALT), GGT, alkaline phosphatase (ALP), fasting glucose, cholesterol and triglyceride levels, uric acid, glycosylated hemoglobin A1c (HbA1c), hepatitis B surface antigen (HBsAg), and antibody to hepatitis C virus (anti-HCV).

Blood samples were obtained in the morning after an overnight fast. Standard liver tests were performed on a multichannel autoanalyzer (Hitachi 7250). HBsAg was measured by a commercially available enzyme immunoassay (Enzygnost, Berling, Germany). Anti-HCV was tested by a second generation enzyme immunoassay (Ortho Diagnostics, Raritan, NJ).

Diagnosis of fatty liver was made using ultrasound according to Saverymuttu et al[14]. The criterion for fatty liver was hyperechoic liver tissue with fine, tightly packed echoes. The degree of fatty change was assessed by the fall in echo amplitude with depth, increasing discrepancy of echo amplitude between liver and kidney, and loss of echoes from the wall of the portal veins.

The presence of diabetes mellitus was defined as fasting blood glucose ≧ 126 mg/dL and/or HbA1c ≧ 6.1[15,16]. The presence of high blood pressure was defined as systolic blood pressure ≧ 140 mmHg and/or diastolic blood pressure ≧ 90 mmHg.

The main endpoint was the identification of the presence or absence of an elevated GGT level combined with clinically associated variables: age, BMI, hypertension, hemoglobin, total cholesterol, triglyceride, uric acid, diabetes mellitus, and fatty liver. All variables were included in a multivariate forward stepwise logistic regression analysis to find the independent predictors of the presence of an elevated GGT level.

Statistical analysis

The continuous variables were compared between the women with and without an elevated GGT level using the 2-tailed Student’s t test. Correlation among these variables was analyzed by Pearson’s correlation coefficient. Categorical variables were compared with Fisher’s exact test. Multivariate analysis was tested using forward stepwise logistic regression analysis. The SPSS statistical software was used for statistical analysis. A P value less than 0.05 was considered statistically significant.

RESULTS

Among 4366 women who received a health check-up, 141 were positive for HBsAg and 14 were positive for anti-HCV (None was positive for both HBsAg and anti-HCV). Persons with either HBsAg or anti-HCV were excluded from this study; the data of the remaining 4211 women was used for the analysis.

Factors correlated with GGT elevation

Univariate analysis Of the 4211 women without hepatitis virus markers, 258(6.1%) showed an elevated GGT level ( > 68 IU/L, reference range: 10-68 IU/L). In comparison, the frequency of raised GGT level in 6620 male health check-up participants (all were negative for both HBsAg and anti-HCV) was 30.2%. When classified into two categories (normal or abnormal, present or absent, above or below), several variables were associated with GGT elevation (Table 1).

Table 1 Univariate analysis of the association between GGT elevation and different variables.
VariableCategorynGGT > 68 IU/L (%)P
Age≧ 502342181(7.7)< 0.0001
< 50186977(4.1)
BMI≧ 251206105(8.7)< 0.0001
< 253 005153(5.1)
Blood pressureHigh56345(8.0)0.047
Normal3 648213(5.8)
Hemoglobin≧ 141153110(9.5)< 0.0001
(g/dL)< 143 058148(4.8)
Cholesterol≧ 2201408122(8.7)< 0.0001
(mg/dL)< 2202803136(4.9)
Triglyceride≧ 15066789(13.3)< 0.0001
(mg/dL)< 1503544169(4.8)
Uric acid≧ 7.015416(10.4)0.025
(mg/dL)< 7.04057242(6.0)
DiabetesPresent18632(17.2)< 0.0001
Absent4025226(5.6)
Fatty liverPresent39136(9.2)0.008
Absent3820222(5.8)

Fatty liver was detected in 391(9.3%) of the 4211 women by using ultrasound. Among the 391 women with fatty liver and 3820 women without fatty liver, correlations of the GGT level with several quantitative variables were assessed. Among the women with fatty liver, age and BMI were not correlated with the GGT level, whereas all variables examined were correlated well with the GGT level in the women without fatty liver. The GGT level was strongly correlated with both AST and ALT, and the correlations were both stronger than that between GGT and ALP (Table 2).

Table 2 Coefficients between GGT and several variables in women with and without fatty Liver (Pearson’s correlation analysis).
VariableWomen withfatty liver (n = 391)P valueWomen withoutfatty liver (n = 3820)P value
Age-0.0350.4850.091< 0.001
BMI0.0220.6700.164< 0.001
SBP0.0780.1220.131< 0.001
DBP0.1010.0460.123< 0.001
Hemoglobin (g/dL)0.1400.0060.100< 0.001
Blood sugar0.1290.0110.195< 0.001
HbA1c (mg/dL)0.1080.0320.186< 0.001
Total cholesterol0.187< 0.0010.134< 0.001
(mg/dL)
Triglyceride0.226< 0.0010.208< 0.001
(mg/dL)
AST (IU/L)0.411< 0.0010.455< 0.001
ALT (IU/L)0.464< 0.0010.524< 0.001
ALP (IU/L)0.272< 0.0010.363< 0.001
Uric acid (mg/dL)0.188< 0.0010.178< 0.001

When the women were divided into 2 groups according to the presence or absence of an elevated triglyceride level, the frequency of GGT elevation did not differ between the women with and without fatty liver. However, the mean GGT level in the women with fatty liver was significantly higher than that in the women without fatty liver (Table 3).

Table 3 Relationship between GGT and fatty liver in women with and without elevated triglyceride (TG) Level.
GGT > 68 IU/l (%)Mean of GGT (GeometricMean ± SD)
Women with elevated TG level (n = 667)89(13.5)32.4 ± 1.9
With fatty liver (n = 137)22(16.1)38.9 ± 1.8
Without fatty liver (n = 530)67(12.6)30.9 ± 1.9b
Women with normal TG level (n = 3544)169(4.8)22.4 ± 1.7
With fatty liver (n = 254)14(5.5)28.2 ± 1.7
Without fatty liver (n = 3290)155(4.7)22.4 ± 1.7b

Multivariate analysis In multiple regression analysis, all independent variables but age were correlated with the GGT level. Although fatty liver was associated with GGT level, the association was weaker than those between the GGT level and the other independent variables (Table 4).

Table 4 Multiple regression analysis of association between logarithmically transformed GGT level and independent variables.
VariableRegression coefficientT valueP value
Age-0.0007-1.770.076
BMI0.00584.82< 0.001
SBP0.00073.360.001
Hemoglobin0.01123.64< 0.001
Total cholesterol0.00043.200.001
Triglyceridea0.216011.38< 0.0001
Uric acid0.03008.23< 0.0001
Diabetes0.11406.45< 0.0001
Fatty liver0.03402.600.009
R20.1630

Although all variables were associated with GGT elevation in univariate analysis (Table 1), the stepwise logistic regression analysis indicated that four variables (age ≧ 50 years, hemoglobin ≧ 14 g/dL, triglyceride ≧ 150 mg/dL, and presence of diabetes) were significantly and independently associated with GGT elevation (Table 4, Table 5). The presence of fatty liver was not independently associated with GGT elevation. In the women with fatty liver (n = 391), only two variables, triglyceride ≧ 150 mg/dL and presence of diabetes, were significantly and independently associated with elevated GGT level (P = 0.003 and P = 0.023, respectively).

Table 5 Factors contributing to elevated GGT level in women (n = 4 211).
Odds ratio95% CIP
Age ≧ 50 years1.41.1-1.90.016
Hemoglobin ≧ 14 g/dL1.61.3-2.1< 0.0001
Triglyceride ≧ 150 mg/dL2.31.7-3.1< 0.0001
Diabetes2.21.5-3.4< 0.0001

Clinical variables predicting the presence of ultrasonographic evidence of fatty liver were also examined by stepwise logistic regression analysis. In all women, four variables were independently associated with the presence of fatty liver: BMI ≧ 25 (P < 0.0001), hemoglobin ≧ 14 g/dL (P = 0.002), triglyceride ≧ 150 mg/dL (P < 0.0001), and uric acid ≧ 7.0 mg/dL (P < 0.0001) (Table 6). The elevated GGT level was not independently correlated with fatty liver.

Table 6 Factors contributing to fatty liver in women (n = 4 211).
Odds ratio95% CIP
BMI ≧ 25 kg/m23.32.8-3.9< 0.0001
Hemoglobin ≧ 14 g/dL1.61.2-2.0< 0.0001
Triglyceride ≧ 150 mg/dL2.31.8-2.9< 0.0001
Uric acid ≧ 7.0 mg/dL1.91.2-2.80.003
DISCUSSION

GGT is one of the biliary enzymes, and is synthesized in epithelial cells of the intrahepatic bile duct[17]. A raised GGT level is usually seen in association with cholestasis and liver cell necrosis[17]. Although GGT is a biliary enzyme, the levels in this study were more strongly associated with transaminase levels, which are associated with liver cell necrosis, as compared with ALP.

Recently, an association between GGT and metabolic syndrome: hypertension[8], dyslipidemia[7], diabetes mellitus[11], has been reported. The mechanism of the association was still unknown, but one of the likely mechanisms proposed is that GGT is associated with fatty liver, which is also related to hepatic insulin resistance leading to insulin resistance syndrome[11].

In this study, the serum GGT level was correlated with metabolic syndrome (hypertension, diabetes mellitus, and dyslipidemia) and risk factors for metabolic syndrome (age, BMI, blood glucose level, and uric acid concentration) in the univariate analysis, whereas, in the multivariate analysis, only four variables were independently associated with the raised GGT level: age ≧ 50 yr, hemoglobin ≧ 14 g/dL, triglyceride ≧ 150 mg/dL, and presence of diabetes mellitus. Age ≧ 50 yr was one of the factors independently associated with GGT elevation, but the association was not seen in the multiple regression analysis. The reason for this discrepancy may be the unique distribution of the age-related prevalence of GGT elevation. The abnormally raised GGT level was most frequently seen in the women of 50-59 years of age.

A relationship between the ultrasonographic evidence of fatty liver and raised GGT level was seen in the univariate analysis, but the relationship was not observed in the multivariate analysis. The triglyceride level was strongly correlated with GGT level and also well associated with fatty liver. The association between the elevated GGT level and fatty liver might be influenced by the strong association between triglyceride and GGT and fatty liver. When the women were divided into two groups according to presence or absence of raised triglyceride level, the frequency of GGT elevation did not differ between the women with and without fatty liver. However, the mean GGT level in the women with fatty liver was significantly higher than that in the women without fatty liver, indicating the positive correlation between GGT level and fatty liver within its normal range.

Both hypertriglyceridemia and diabetes mellitus were independently associated with GGT elevation. Triglyceride level and diabetes mellitus are known to be strongly associated with insulin level and are included in metabolic syndrome[8,18]. Moreover, hyperinsulinemia was reported to be associated with raised GGT level[7]. Raised GGT level is associated with insulin resistance, which is related to an increase in oxidative stress, which leads to liver cell necrosis by stimulating inflammatory cytokines[10]. Fatty liver may not always mediate between insulin resistance and raised GGT levels. For example, diabetes mellitus is the representative condition of the sequelae of insulin resistance and independently associated with raised GGT level, but many diabetic persons do not have fatty liver.

In this study, GGT was correlated with an elevated hemoglobin level. Insulin resistance status increases delivery of free fatty acids to the liver[10], which leads to the formation of free radicals[10]. Formation of free radicals is also induced by iron overload[19], which is associated with insulin resistance[20,21]. Liver iron concentration is correlated with serum ferritin levels and peripheral hemoglobin concentration[21,22]. Obesity, which is linked with an elevated hemoglobin level, is associated with arterial hypoxemia, which may result from reduced pulmonary function[23,24]. Sleep apnea syndrome is frequently seen in obese persons[25,26], and is associated with hypoxemia and elevated levels of hemoglobin.

The serum GGT level is a well known indicator of excess alcohol intake. GGT is also raised in patients with various liver diseases: fatty liver, chronic viral hepatitis, drug-induced liver injury and primary biliary cirrhosis (PBC). These liver diseases are usually asymptomatic, and can be included in general-population studies[27]. Patients with chronic viral hepatitis were supposed to be excluded from this study because all women included in this study were negative for both HBsAg and anti-HCV. However, we did not take a history regarding past or current medication, nor did we examine anti-mitochondrial antibody. Hence, our study population might contain patients with subclinical drug-induced liver injury and those with asymptomatic PBC. Neverthless, the influence of the presence of these liver diseases might be small because of the rarity of these liver diseases in a population-based study.

In this study, we enrolled only women, but the annual health check-ups include many men. General population studies from Japan showed that 73% of males having health check-ups drank alcohol and that 12.5% of them drank more than 453 mL/wk[8,10]. Obtaining information on alcohol intake from family members who are in close contact with each other is difficult in population-based studies. We therefore excluded male health check-up participants from this study to minimize the possibility of including alcohol-related liver disease. Most female health check-up participants had no regular alcohol intake. We previously interviewed 140 female health check-up participants who had an elevated GGT level and only two (1.4%) of them had a history of regular alcohol intake. The subjects of this study may have included some women with a history of regular alcohol intake, but the influence of alcohol might be quite small and might not affect the whole data.

In conclusion, GGT elevation was independently associated with hypertriglyceridemia and diabetes mellitus but not associated with the ultrasonographic evidence of fatty liver. Metabolic syndrome seemed to be directly, not indirectly through fatty liver, associated with the raised GGT level in Japanese women.

ACKNOWLEDGEMENT

We are grateful to Dr. Kozen Kinjo and other staff members in the Okinawa General Health Service Association for their kind cooperation.

Footnotes

Edited by Zhu LH and Xu FM

References
1.  Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res. 1997;5:542-548.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 333]  [Cited by in F6Publishing: 342]  [Article Influence: 12.7]  [Reference Citation Analysis (0)]
2.  Hamaguchi K, Sakata T. Epidemiology of obesity. Kan Tan Sui. 2001;42:9-18.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635-643.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2964]  [Cited by in F6Publishing: 2800]  [Article Influence: 84.8]  [Reference Citation Analysis (0)]
5.  Moller DE, Flier JS. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med. 1991;325:938-948.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 503]  [Cited by in F6Publishing: 476]  [Article Influence: 14.4]  [Reference Citation Analysis (0)]
6.  Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761-811.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248:230-238.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 100]  [Cited by in F6Publishing: 103]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
8.  Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens. 1995;9:101-105.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, Li JQ, Chen SY. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol. 2003;9:1106-1110.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Harrison SA, Kadakia S, Lang KA, Schenker S. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol. 2002;97:2714-2724.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 16]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
11.  Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care. 1998;21:732-737.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 245]  [Cited by in F6Publishing: 249]  [Article Influence: 9.6]  [Reference Citation Analysis (0)]
12.  Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988;27:142-149.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 228]  [Cited by in F6Publishing: 235]  [Article Influence: 6.5]  [Reference Citation Analysis (0)]
13.  Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994. Int J Obes Relat Metab Disord. 1998;22:684-687.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 145]  [Cited by in F6Publishing: 150]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
14.  Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292:13-15.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 584]  [Cited by in F6Publishing: 597]  [Article Influence: 15.7]  [Reference Citation Analysis (0)]
15.  The committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes Mellitus. Report of the committee of Japan Diabetes Society on the classification and Diagnostic Criteria of Diabetes Mellitus. J Jpn Diabetes Soc. 1999;42:385-404.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Takahashi Y, Noda M, Tsugane S, Kuzuya T, Ito C, Kadowaki T. Prevalence of diabetes estimated by plasma glucose criteria combined with standardized measurement of HbA1c among health checkup participants on Miyako Island, Japan. Diabetes Care. 2000;23:1092-1096.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 35]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
17.  Nemesánszky E, Lott JA. Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin Chem. 1985;31:797-803.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KG. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol. 1996;144:224-234.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 59]  [Cited by in F6Publishing: 65]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
19.  Bacon BR, O'Neill R, Britton RS. Hepatic mitochondrial energy production in rats with chronic iron overload. Gastroenterology. 1993;105:1134-1140.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V, Deugnier Y. Insulin resistance-associated hepatic iron overload. Gastroenterology. 1999;117:1155-1163.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 355]  [Cited by in F6Publishing: 335]  [Article Influence: 13.4]  [Reference Citation Analysis (0)]
21.  Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol. 2001;96:2448-2455.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 158]  [Cited by in F6Publishing: 170]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
22.  Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology. 1997;25:759-768.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 247]  [Cited by in F6Publishing: 248]  [Article Influence: 9.2]  [Reference Citation Analysis (0)]
23.  Luce JM. Respiratory complications of obesity. Chest. 1980;78:626-631.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 158]  [Cited by in F6Publishing: 136]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
24.  Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128:501-506.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Messinezy M, Pearson TC. A retrospective study of apparent and relative polycythaemia: associated factors and early outcome. Clin Lab Haematol. 1990;12:121-129.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Coughlin S, Calverley P, Wilding J. Sleep disordered breathing--a new component of syndrome x? Obes Rev. 2001;2:267-274.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 30]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
27.  Inoue K, Hirohara J, Nakano T, Seki T, Sasaki H, Higuchi K, Ohta Y, Onji M, Muto Y, Moriwaki H. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver. 1995;15:70-77.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 61]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]